The aryl hydrocarbon receptor controls mesenchymal stromal cell-mediated immunomodulation via ubiquitination of eukaryotic elongation factor-2 kinase
Abstract Mesenchymal stem cells (MSCs) have great therapeutic advantages due to their immunosuppressive properties. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor whose signaling plays an important role in the immune system. AHR may be involved in the regulation of MS...
Main Authors: | Enkhmaa Lkhagva-Yondon, Myeong Seong Seo, Yena Oh, Jonghun Jung, Eunhae Jeon, Kwangmin Na, Hyun Seung Yoo, Woo Chul Kim, Charlotte Esser, Sun U. Song, Myung-Shin Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-12-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06341-7 |
Similar Items
-
Structure of a new nucleic-acid-binding motif in eukaryotic transcriptional elongation factor TFIIS
by: Weiss, Michael A., et al.
Published: (2012) -
Trajectory Shifts in Interdisciplinary Research of the Aryl Hydrocarbon Receptor—A Personal Perspective on Thymus and Skin
by: Charlotte Esser
Published: (2021-02-01) -
Novel domains and orthologues of eukaryotic transcription elongation factors.
by: Ponting, C
Published: (2002) -
Exploring BenzylethoxyAryl Urea Scaffolds for Multitarget Immunomodulation Therapies
by: Raquel Gil-Edo, et al.
Published: (2023-05-01) -
The aryl hydrocarbon receptor regulates lipid mediator production in alveolar macrophages
by: Ann-Marie Maier, et al.
Published: (2023-04-01)